Rheumatology Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Rhode island, 88 of them are under age 60. They only represent a small percentage of those who are dying, but they have three times the chance of becoming hospitalized. So if what were trying to do is to really flatten the curve so we dont overwhelm the health care system, the last thing you want is for more people to get infected regardless of the age, and especially if were talking about latinos. You dont want latinos to get infected. All right, dr. Pablo rodriguez, we really appreciate you joining us. Thank you so much. Thank you for having me. Were going to continue with cnns special cover...

Growing evidence suggests that a guideline-directed, treat-to-target strategy in patients with gout not only controls the disease but also reduces cardiovascular risks.

Colchicine, a legacy drug that received a new indication in 2023 for cardiovascular disease, can treat arterial inflammation after a heart attack, a principal investigator of clinical trials said.

Researchers report that severe cases of psoriasis can affect a person's blood flow and subsequently increase their risk of cardiovascular disease

Yale provides cardiovascular risk assessment and treatment for patients with autoimmune diseases, including rheumatoid arthritis, systemic lupus, scleroderma,